Overview
Fenoterol is an adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
Indication
用于哮喘（包括夜间哮喘和运动性哮喘）、喘息性支气管炎和可逆性气道阻塞。
Associated Conditions
- Asthma Attack
- Bronchial Asthma
- Exercised Induced Asthma
- Severe COPD exacerbation
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2022/03/24 | Early Phase 1 | Completed | University Hospital, Basel, Switzerland | ||
2014/09/19 | N/A | Completed | |||
2014/06/27 | Phase 3 | Terminated | |||
2014/02/04 | Phase 1 | Completed | University Medical Center Goettingen | ||
2011/09/26 | Phase 1 | Completed | National Institute on Aging (NIA) | ||
2010/03/29 | Phase 3 | Completed | Taiwan Otsuka Pharm. Co., Ltd |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| BERODUAL SOLUTION | SIN02664P | SOLUTION | 0.5 mg/ml | 4/28/1989 | |
| DUOVENT UDVS NEBULISER SOLUTION | SIN07913P | SOLUTION | 1.25 mg/4 ml | 11/15/1994 | |
| BERODUAL N METERED DOSE INHALER | SIN11739P | AEROSOL, SPRAY | 50 mcg/dose | 11/30/2001 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| BEROTEC UDV INHALATION SOLUTON 0.625MG/ML | boehringer ingelheim (canada) ltd ltee | 02056704 | Solution - Inhalation
,
Oral | 0.625 MG / ML | 12/31/1994 |
| BEROTEC TAB 2.5MG | boehringer ingelheim (canada) ltd ltee | 00454796 | Tablet - Oral | 2.5 MG | 12/31/1979 |
| BEROTEC 1MG/ML | boehringer ingelheim (canada) ltd ltee | 00541389 | Solution - Inhalation | 1 MG / ML | 12/31/1982 |
| BEROTEC FORTE METERED AER | boehringer ingelheim (canada) ltd ltee | 00371807 | Metered-Dose Aerosol - Inhalation
,
Oral | 0.2 MG / NS | 12/31/1977 |
| DUOVENT UDV | boehringer ingelheim (canada) ltd ltee | 02148633 | Solution - Oral
,
Inhalation | 0.3125 MG / ML | 12/31/1995 |
| BEROTEC AEM 100MCG/DOSE | boehringer ingelheim (canada) ltd ltee | 02006383 | Metered-Dose Aerosol - Inhalation
,
Oral | 100 MCG / ACT | 12/31/1992 |
| BEROTEC UDV INHALATION SOLUTION 0.25MG/ML | boehringer ingelheim (canada) ltd ltee | 02056712 | Solution - Inhalation
,
Oral | 0.25 MG / ML | 12/31/1994 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.